Hhamclav DS Dry Syrup is a combination antibiotic formulation containing Amoxycillin 400 mg and Clavulanic Acid 57 mg per 5 ml of reconstituted suspension. Amoxycillin is a broad-spectrum beta-lactam antibiotic effective against a wide range of gram-positive and gram-negative bacteria by inhibiting bacterial cell wall synthesis. Clavulanic Acid is a beta-lactamase inhibitor that protects Amoxycillin from enzymatic degradation by beta-lactamase-producing bacteria, thereby extending its antimicrobial spectrum. Hhamclav DS is indicated for the treatment of various bacterial infections including respiratory tract infections, otitis media, sinusitis, skin and soft tissue infections, urinary tract infections, and dental infections caused by susceptible organisms. The dry syrup formulation is suitable for pediatric patients and those unable to swallow tablets, ensuring accurate dosing and improved compliance. The medication should be reconstituted with the specified amount of water before administration and stored as directed to maintain stability. Dosage and duration of therapy should be determined by a healthcare professional based on the severity of infection, patient age, and renal function. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and vomiting. Hypersensitivity reactions may occur in penicillin-allergic individuals; therefore, caution is advised. Hhamclav DS should be used under medical supervision to ensure optimal therapeutic outcomes and minimize resistance development.